News | October 30, 2008

ASTRO 2008 Attendance Reached All-Time-High at 12,487

October 30, 2008 - The American Society for Therapeutic Radiology and Oncology (ASTRO) welcomed 12,487 people to its 50th Annual Meeting held September 21- 25, 2008, at the Boston Convention and Exhibition Center, marking an all-time high for an ASTRO Annual Meeting.

The ASTRO Annual Meeting attendees include oncologists, physicists, biologists, nurses and other healthcare professionals from all over the world. The theme of the 2008 meeting was 50 Years of Learning

"This year was an extremely successful year for our Annual Meeting," Laura I. Thevenot, ASTRO's chief executive officer, said. "I am very proud of our dedicated staff and leadership for all of their hard work in making our 50th anniversary meeting one of our best ever."

Caring and Collaboration in the Treatment of Cancer Patients and the program highlighted the accomplishments of ASTRO's past, while addressing lessons learned in radiation oncology and goals for the future of the specialty.

ASTRO's 51st Annual Meeting will be held November 1-5, 2009, at McCormick Place in Chicago.

For more information: www.astro.org

Related Content

First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Overlay Init